glp 1/ Glucagon-like peptide-1 ONE + Receptor Activator features two clinically validated botanical ingredients List of approved and pending

Palmer SC, Tendal B, Mustafa RA et al (2021) Sodiumglucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

How to Notify Clients of This Update For your clients with a Part D plan that could qualify for GLP-1 coverage as part of the GENEROUS model, let them know to speak to their doctor about these treatments if they are interested

This can be genetic

Their protein content can aid in making you feel full and can potentially ramp up the production of GLP-1

Freitas S, Merkle HP, Gander B

The procedure should be documented appropriately by a medical or scientific professional